姓名：余俊先 性别：男 职称：主任药师、副教授 招生院所：附属友谊医院 招生类型：专业学位(硕) 招生专业：临床药学(硕) 研究方向名称：肿瘤药学 电子信箱：junxianyu@ccmu.edu.cn


社会任职
1. 《医药包装 &用药安全》编委
2. 北京市内分泌代谢病学会诊疗安全与费效评价专业委员会委员
3. 中国非处方药物协会自我药疗教育专业委员会委员
4. 国家药典委员会药品质量标准与临床应用工作委员会委员
5. 北京医学奖励基金会药学专业委员会委员
6. 北京市肿瘤治疗质量控制改进中心肿瘤化疗质控专家委员会委员
个人简历
1. 200309-200607:南京医科大学 博士研究生
2. 200608-:首都医科大学附属北京友谊医院 主任药师/副教授
3. 201409-201503:Texas Tech University, U.S.A 访问
重要学术论文
1. Wu J, Wang J, Su Q, Ding W, Li T, Yu J*(余俊先）, Cao B*..Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis.. Onco Targets Ther. 2018,11:2685-2698.SCI
2. Geng F, Wang Z, Yin H, Yu J(余俊先)*, Cao B*.Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives.. Cancer Biother Radiopharm. 2017,32(5):149-160.SCI
3. Geng F, Yin H, Li Z Li Q, He C, Wang Z, Yu J(余俊先)*.Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC-MS/MS and the study of its pharmacokinetics and bioavailability. Biomed Pharmacother. 2017,95:1479-1485.SCI
4. Wen A, Li Z, Yu J(余俊先), Li R, Cheng S, Duan M, Bai J.Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study. PLoS One. 2016,11(4):e**.SCI
5. Yu J(余俊先), Li Z, Wang W, Zhang Y, Li D, Liu Y, Shen S, Zhang R.Anticancer 20(R)-dammarane- 3,12,20,25-tetrol-loaded polymericmicelles: Preparation, quantification and pharmacokinetics. J Chromatogr B Analyt Technol Biomed Life Sci. 2016,1022:13-20.SCI
6. Yu J(余俊先), Liu C, Li Z, Zhang C, Wang Z, Liu X.Inhibitory effects and mechanism of 25-OH-PPD on glomerular mesangial cell proliferation induced by high glucose. Environ Toxicol Pharmacol. 2016,44:93-98.SCI
7. Li Z, Li Q, Wu J, Wang M, Yu J(余俊先)*.Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?. Molecules. 2016,21(10):pii: E1331.SCI
8. Li D, Wang T, Shen S, Cheng S, Yu J(余俊先), Zhang Y, Zhang C, Tang H.Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis. PLoS One. 2015,10(12):e**.SCI
9. Yu JX(余俊先), Voruganti S, Li DD, Qin JJ, Nag S, Xu S, Velu SE, Wang W, Zhang R.Development and validation of an HPLC-MS/MS analytical method for quantitative analysis of TCBA-TPQ, a novel anticancer makaluvamine analog, and application in a pharmacokinetic study in rats.. Chin J Nat Med. 2015,13(7):554-560.SCI
10. J Yu(余俊先)*, Subhasree A. Nag, Ruiwen Zhang*.Advances in translational pharmacological investigations in identifying and validating molecular targets of natural product anticancer agents.. Current Cancer Drug Targets. 2013,13(5) :596-609.SCI
主编或副主编的著作/译著
1. 《TU YOUYOU’S JOURNEY IN THE SEARCH FOR ARTEMISININ》,主译,化学工业出版社,201712
2. 《养好肠胃一本就会》,主编,化学工业出版社,201709
重要奖项
1. 肾移植受者术后肌酐清除率对咪唑立宾血药浓度影响及其意义 2016年北京药学年会“扬子江杯”优秀论文奖 二等奖 201612
2. 2015年度癌痛诊疗质控”药学管理示范单位 北京市癌痛治疗质量控制和改进中心督导检查结果表彰 示范单位 201512
3. 人参皂苷PPD聚合物胶束的代谢与组织分布研究 2014北京药学年会“扬子江杯”优秀论文奖 三等奖 201412
4. LC-MS/MS法测定海洋生物碱TCBA-TPQ的浓度及其药动学研究 2014北京药学年会“扬子江杯”优秀论文奖 三等奖 201412